Olopatadine Hydrochloride (Rising Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Olopatadine Hydrochloride drug offered from Rising Pharmaceuticals, Inc.. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Rising Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Olopatadine Hydrochloride USP, 0.1% |
| SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-12-07 |
| END MARKETING DATE: | 0000-00-00 |
Olopatadine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Olopatadine Hydrochloride from Rising Pharmaceuticals, Inc. |
| LABELER NAME: | Rising Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2015-12-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64980-517_1efeb3f3-27fa-4e41-8689-17a91937436a |
| PRODUCT NDC: | 64980-517 |
| APPLICATION NUMBER: | ANDA203152 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
